Detalhe da pesquisa
1.
Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.
Mod Rheumatol
; 34(2): 307-312, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943727
2.
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching.
Mod Rheumatol
; 33(3): 472-480, 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695707
3.
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.
Mod Rheumatol
; 33(1): 64-72, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365828
4.
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Mod Rheumatol
; 33(4): 668-679, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920102
5.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Mod Rheumatol
; 33(4): 657-667, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921235
6.
Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-α inhibitors or IL-6 inhibitors.
Clin Exp Rheumatol
; 40(11): 2060-2070, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084317
7.
Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose: post hoc analysis of a randomized, placebo-controlled, phase 4 study.
Mod Rheumatol
; 32(3): 500-507, 2022 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897499
8.
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Mod Rheumatol
; 32(1): 59-67, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274687
9.
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Mod Rheumatol
; 32(2): 263-272, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910188
10.
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Mod Rheumatol
; 32(2): 273-283, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910203
11.
Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study.
Clin Exp Rheumatol
; 38(3): 398-404, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287398
12.
A randomized double-blind parallel-group phase III study to compare the efficacy and safety of NI-071 and infliximab reference product in Japanese patients with active rheumatoid arthritis refractory to methotrexate.
Mod Rheumatol
; 29(6): 919-927, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289287
13.
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial.
Ann Rheum Dis
; 76(8): 1348-1356, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153828
14.
Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis.
Mod Rheumatol
; 27(2): 271-277, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27416107
15.
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
Ann Rheum Dis
; 75(1): 75-83, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26139005
16.
The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis.
Mod Rheumatol
; 26(1): 51-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26052803
17.
Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan.
Rheumatology (Oxford)
; 54(4): 683-91, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257039
18.
Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome.
J Clin Biochem Nutr
; 57(2): 140-4, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26388672
19.
Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders.
Mod Rheumatol
; 25(5): 665-71, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698370
20.
Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.
Ann Rheum Dis
; 73(3): 536-43, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23316080